Market Overview

Mid-Day Market Update: Crude Oil Rises 2%; Eastman Kodak Shares Plummet

Share:

Midway through trading Monday, the Dow traded up 1.07% to 27728.03 while the NASDAQ fell 0.65% to 10938.99. The S&P also rose, gaining 0.13% to 3,355.63.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 5,045,560 cases with around 162,930 deaths. Brazil confirmed a total of over 3,035,420 COVID-19 cases with 101,040 deaths, while India reported a total of at least 2,215,070 confirmed cases and 44,380 deaths. In total, there were at least 19,876,300 cases of COVID-19 worldwide with over 731,570 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares gained 2.1% on Monday. Meanwhile, top gainers in the sector included Penn Virginia Corporation (NASDAQ: PVAC), up 14%, and Centrus Energy Corp. (NYSE: LEU), up 12%.

In trading on Monday, information technology shares fell by 0.7%.

Top Headline

Marriott International Inc (NASDAQ: MAR) reported a wider-than-expected loss for its second quarter, while sales missed views.

Marriott International posted a Q2 loss of $0.64 per share, wider than analysts’ estimates for a loss of $0.42 per share. The company reported quarterly sales of $1.46 billion, missing expectations of $1.68 billion.

Equities Trading UP

Seres Therapeutics, Inc. (NASDAQ: MCRB) shares shot up 351% to $20.91 after the company announced the results from its SER-109 Phase 3 ECOSPOR III study in recurrent C. difficile infection met the primary endpoint.

Shares of Omeros Corporation (NASDAQ: OMER) got a boost, shooting 45% to $20.55 after the biopharma announced results from a compassionate use study of its lead investigational human monoclonal antibody. Omeros said its narsoplimab, when administered to six COVID-19 patients with Acute Respiratory Distress Syndromewho initially required mechanical ventilation, led to recovery, survival and discharge from the hospital.

Trevena, Inc. (NASDAQ: TRVN) shares were also up, gaining 30% to $3.09 after the company disclosed that the FDA has approved its OLINVYK injection.

Equities Trading DOWN

Eastman Kodak Company (NYSE: KODK) shares tumbled 29% to $10.50. The federal government is halting a $765 million loan to Eastman Kodak for its generic drug-making foray until the company is cleared of insider trading allegations.

Shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) were down 33% to $104.30 following Q2 results. Reata Pharmaceuticals posted a Q2 loss of $1.23 per share on revenue of $3.07 million.

Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) was down, falling 29% to $3.40 after the company signed binding framework for commercialization partnership with Jubilant Radiopharma. The company also secured $25 million of committed financing.

Commodities

In commodity news, oil traded up 2% to $42.04, while gold traded up 0.8% to $2,044.70.

Silver traded up 5.2% Monday to $28.965, while copper rose 2.5% to $2.863.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.29%, the Spanish Ibex Index rose 1.4%, while Italy’s FTSE MIB Index gained 0.47%. Meanwhile, the German DAX 30 gained 0.04%, French CAC 40 rose 0.32% and UK shares rose 0.31%.

Economics

The number of job openings rose by 518,000 to 5.9 million in June, exceeding analysts’ estimates of 4.91 million.

The TD Ameritrade Investor Movement Index for July will be released at 12:30 p.m. ET.

 

Related Articles (KODK + LEU)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com